Search research articles
Contact Us
Filters
Showing results (51-60 of 117) with videos related to
Page
of 12
Sort By:
American Journal of Clinical Oncology
|
November 3, 2015
FOLFOX+Nab-Paclitaxel (FOLFOX-A) for Advanced Pancreatic Cancer: A Brown University Oncology Research Group Phase I Study
Howard Safran, Kevin P Charpentier, Kimberly Perez, et al.
American Journal of Clinical Oncology
|
December 1, 2005
Erlotinib and chemoradiation followed by maintenance erlotinib for locally advanced pancreatic cancer: a phase I study
David Iannitti, Tom Dipetrillo, Paul Akerman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 26, 2008
Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704
Adam C Berger, Miguel Garcia, John P Hoffman, et al.
American Journal of Clinical Oncology
|
September 30, 2009
Cetuximab, paclitaxel, carboplatin, and radiation for head and neck cancer: a toxicity analysis
Ariel Birnbaum, Thomas Dipetrillo, Ritesh Rathore, et al.
Oncotargets and Therapy
|
September 15, 2012
Weekly paclitaxel, gemcitabine, and external irradiation followed by randomized farnesyl transferase inhibitor R115777 for locally advanced pancreatic cancer
Tyvin A Rich, Kathryn Winter, Howard Safran, et al.
The Oncologist
|
March 18, 2016
Electrocardiographic Characterization of Ramucirumab on the Corrected QT Interval in a Phase II Study of Patients With Advanced Solid Tumors
Anthony J Olszanski, David C Smith, Luis H Camacho, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 12, 2012
Five year results of US intergroup/RTOG 9704 with postoperative CA 19-9 ≤90 U/mL and comparison to the CONKO-001 trial
Adam C Berger, Kathryn Winter, John P Hoffman, et al.
Frontiers in Oncology
|
June 6, 2012
A Phase I Study of Dasatinib with Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer
Humera Khurshid, Thomas Dipetrillo, Thomas Ng, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 6, 2007
Cetuximab with concurrent chemoradiation for esophagogastric cancer: assessment of toxicity
Howard Safran, Mohan Suntharalingam, Thomas Dipetrillo, et al.
Annals of Surgical Oncology
|
April 19, 2011
Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial
William F Regine, Kathryn A Winter, Ross Abrams, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 117) with videos related to
Sort By:
Page
of 12
American Journal of Clinical Oncology
|
November 3, 2015
FOLFOX+Nab-Paclitaxel (FOLFOX-A) for Advanced Pancreatic Cancer: A Brown University Oncology Research Group Phase I Study
Howard Safran, Kevin P Charpentier, Kimberly Perez, et al.
American Journal of Clinical Oncology
|
December 1, 2005
Erlotinib and chemoradiation followed by maintenance erlotinib for locally advanced pancreatic cancer: a phase I study
David Iannitti, Tom Dipetrillo, Paul Akerman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 26, 2008
Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704
Adam C Berger, Miguel Garcia, John P Hoffman, et al.
American Journal of Clinical Oncology
|
September 30, 2009
Cetuximab, paclitaxel, carboplatin, and radiation for head and neck cancer: a toxicity analysis
Ariel Birnbaum, Thomas Dipetrillo, Ritesh Rathore, et al.
Oncotargets and Therapy
|
September 15, 2012
Weekly paclitaxel, gemcitabine, and external irradiation followed by randomized farnesyl transferase inhibitor R115777 for locally advanced pancreatic cancer
Tyvin A Rich, Kathryn Winter, Howard Safran, et al.
The Oncologist
|
March 18, 2016
Electrocardiographic Characterization of Ramucirumab on the Corrected QT Interval in a Phase II Study of Patients With Advanced Solid Tumors
Anthony J Olszanski, David C Smith, Luis H Camacho, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 12, 2012
Five year results of US intergroup/RTOG 9704 with postoperative CA 19-9 ≤90 U/mL and comparison to the CONKO-001 trial
Adam C Berger, Kathryn Winter, John P Hoffman, et al.
Frontiers in Oncology
|
June 6, 2012
A Phase I Study of Dasatinib with Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer
Humera Khurshid, Thomas Dipetrillo, Thomas Ng, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 6, 2007
Cetuximab with concurrent chemoradiation for esophagogastric cancer: assessment of toxicity
Howard Safran, Mohan Suntharalingam, Thomas Dipetrillo, et al.
Annals of Surgical Oncology
|
April 19, 2011
Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial
William F Regine, Kathryn A Winter, Ross Abrams, et al.
Page
of 12